Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Antiretroviral activity of ancestral TRIM5alpha.

Goldschmidt V, Ciuffi A, Ortiz M, Brawand D, Muñoz M, Kaessmann H, Telenti A.

J Virol. 2008 Mar;82(5):2089-96.

2.

Retrovirus restriction by TRIM5alpha variants from Old World and New World primates.

Song B, Javanbakht H, Perron M, Park DH, Stremlau M, Sodroski J.

J Virol. 2005 Apr;79(7):3930-7.

3.

Unique spectrum of activity of prosimian TRIM5alpha against exogenous and endogenous retroviruses.

Rahm N, Yap M, Snoeck J, Zoete V, Muñoz M, Radespiel U, Zimmermann E, Michielin O, Stoye JP, Ciuffi A, Telenti A.

J Virol. 2011 May;85(9):4173-83. doi: 10.1128/JVI.00075-11.

4.

Adaptive evolution of primate TRIM5alpha, a gene restricting HIV-1 infection.

Liu HL, Wang YQ, Liao CH, Kuang YQ, Zheng YT, Su B.

Gene. 2005 Dec 5;362:109-16.

PMID:
16226405
5.
6.

Comparative requirements for the restriction of retrovirus infection by TRIM5alpha and TRIMCyp.

Diaz-Griffero F, Kar A, Lee M, Stremlau M, Poeschla E, Sodroski J.

Virology. 2007 Dec 20;369(2):400-10.

7.
8.

Functional evidence for the involvement of microtubules and dynein motor complexes in TRIM5α-mediated restriction of retroviruses.

Pawlica P, Le Sage V, Poccardi N, Tremblay MJ, Mouland AJ, Berthoux L.

J Virol. 2014 May;88(10):5661-76. doi: 10.1128/JVI.03717-13.

9.

Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha.

Hatziioannou T, Perez-Caballero D, Yang A, Cowan S, Bieniasz PD.

Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10774-9.

10.

Role of common human TRIM5alpha variants in HIV-1 disease progression.

Goldschmidt V, Bleiber G, May M, Martinez R, Ortiz M, Telenti A; Swiss HIV Cohort Study..

Retrovirology. 2006 Aug 22;3:54.

11.

The antiviral spectra of TRIM5α orthologues and human TRIM family proteins against lentiviral production.

Ohmine S, Sakuma R, Sakuma T, Thatava T, Takeuchi H, Ikeda Y.

PLoS One. 2011 Jan 14;6(1):e16121. doi: 10.1371/journal.pone.0016121.

12.

Trim5alpha protein restricts both HIV-1 and murine leukemia virus.

Yap MW, Nisole S, Lynch C, Stoye JP.

Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10786-91.

14.

The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates.

Song B, Gold B, O'Huigin C, Javanbakht H, Li X, Stremlau M, Winkler C, Dean M, Sodroski J.

J Virol. 2005 May;79(10):6111-21.

15.
16.

Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain.

Sawyer SL, Wu LI, Emerman M, Malik HS.

Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2832-7.

17.

Restriction of an extinct retrovirus by the human TRIM5alpha antiviral protein.

Kaiser SM, Malik HS, Emerman M.

Science. 2007 Jun 22;316(5832):1756-8.

18.

Patterns of evolution of host proteins involved in retroviral pathogenesis.

Ortiz M, Bleiber G, Martinez R, Kaessmann H, Telenti A.

Retrovirology. 2006 Feb 7;3:11. Review.

19.

Proteasomal degradation of TRIM5alpha during retrovirus restriction.

Rold CJ, Aiken C.

PLoS Pathog. 2008 May 23;4(5):e1000074. doi: 10.1371/journal.ppat.1000074.

20.

The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.

Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J.

Nature. 2004 Feb 26;427(6977):848-53.

PMID:
14985764

Supplemental Content

Support Center